(S)-1-Methyl-5-(pyridin-3-yl)pyrrolidin-2-one, 95.0%, 250mg

1-tert-Butyl 2-methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1,2-dicarboxylate, 95.0%, 5g

N,N-Bis(2-chloroethyl)propan-1-amine hydrochloride, 97%, 1g

(+/-)-Thalidomide, 98%, 10g

1-Methyl-1H-indole-5-carbonitrile, 95.0%, 100g

Conductivity standard ROTI®Calipure, 20000 µS/cm (25 °C), 500 ml, plastic packaging.

N,N,2-Trimethyl-5-nitrobenzenesulfonamide, 98.0%, 50mg

2,3-diphenylquinoxaline-5-carboxylic acid, 95.0%, 2g

(1-Methyl-2-oxo-1,2-dihydropyridin-4-yl)boronic acid, 95.0%, 25g

Polydimethylsiloxane, trimethylsiloxy terminated 1,000cSt, 3kg

(R)-2-Aminopent-4-ynoic acid, 95.0%, 100mg

2-Bromo-5-nitropyridine, 98.0%, 500g